Artemisinin-based combination therapy for ... - The Cochrane Library

Adjuik 2004
Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N,
International Artemisinin Study Group. Artesunate combinations
for treatment of malaria: meta-analysis. The Lancet 2004;363
(9402):9–17.
Agomo 2008
Agomo PU, Meremikwu MM, Watila IM, Omalu IJ, Odey FA,
Oguche S, et al.Efficacy, safety and tolerability of artesunatemefloquine
in the treatment of uncomplicated Plasmodium
falciparum malaria in four geographic zones of Nigeria. Malaria
Journal 2008;7:172.
Bukirwa 2005
Bukirwa H, Orton L. Artesunate plus mefloquine versus
mefloquine for treating uncomplicated malaria. Cochrane Database
of Systematic Reviews 2005, Issue 4. [DOI: DOI: 10.1002/
14651858.CD004531.pub2]
Bukirwa 2006
Bukirwa H, Critchley J. Sulfadoxine-pyrimethamine plus artesunate
versus sulfadoxine-pyrimethamine plus amodiaquine for treating
uncomplicated malaria. Cochrane Database of Systematic Reviews
2006, Issue 1. [DOI: 10.1002/14651858.CD004966.pub2]
Cattamanchi 2003
Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey
G. Distinguishing recrudescence from reinfection in a longitudinal
antimalarial drug efficacy study: comparison of results based on
genotyping of msp-1, msp-2, and glurp. American Journal of
Tropical Medicine and Hygiene 2003;68(2):133–9.
Guyatt 2008
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y,
Schünemann HJ. GRADE Working Group.Rating quality of
evidence and strength of recommendations: What is “quality of
evidence” and why is it important to clinicians?. BMJ 2008;336
(7651):995–8.
Higgins 2008
Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of
bias in included studies. In: Higgins JPT, Green S (editors),
Cochrane Handbook of Systematic Reviews of Intervention.
Version 5.0.0 (updated February 2008). The Cochrane
Collaboration, 2008. Available from www.cochrane-handbook.org.
Chichester: John Wiley & Sons Ltd.
Lefebvre 2008
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for
studies. In: Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.0.0 (updated
February 2008). The Cochrane Collaboration, 2008. Available
from www.cochrane-handbook.org.
Massougbodji 2002
Massousgbodji A, Kone Kinde Gazard D, same-Ekobo A, Cambon
N, Mueller EA. A randomized double-blind study on the efficacy
and safety of a practical three-day regimen with artesunate and
mefloquine for the treatment of uncomplicated Plasmodium
falciparum malaria in Africa. Transactions of the Royal Society of
Tropical Medicine and Hygiene 2002;96(6):655–659.
Artemisinin-based combination therapy for treating uncomplicated malaria (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mayxay 2004
Mayxay M, Pukrittayakamee S, Newton PN, White NJ. Mixedspecies
malaria infections in humans. Trends in Parasitology 2004;
20(5):233–40.
McIntosh 1999
McIntosh HM, Olliaro P. Artemisinin derivatives for treating
uncomplicated malaria. Cochrane Database of Systematic Reviews
1999, Issue 2. [DOI: 10.1002/14651858.CD000256]
Meshnick 1996
Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and
the antimalarial endoperoxides: from herbal remedy to targeted
chemotherapy. Microbiological Reviews 1996;60(2):301–15.
Newton 2002
Newton PN, van Vugt M, Teja-Isavadharm P, Siriyanonda D,
Rasameesoroj M, Teerapong P, et al.Comparison of oral artesunate
and dihydroartemisinin antimalarial bioavailabilities in acute
Falciparum malaria. Antimicrobial Agents Chemotherapy 2002;46
(4):1125–7.
Nosten 2007
Nosten F, White NJ. Artemisinin-based combination treatment of
falciparum malaria. American Journal of Tropical Medicine and
Hygiene 2007;77 (6 Suppl):181–92.
Omari 2005
Omari AAA, Gamble C, Garner P. Artemether-lumefantrine (sixdose
regimen) for treating uncomplicated falciparum malaria.
Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI:
10.1002/14651858.CD005564]
Omari 2006
Omari AAA, Gamble C, Garner P. Artemether-lumefantrine (fourdose
regimen) for treating uncomplicated falciparum malaria.
Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI:
10.1002/14651858.CD005965]
Price 1996
Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L,
Chongsuphajaisiddhi T, et al.Effects of artemisinin derivatives on
malaria transmissibility. The Lancet 1996;347(9016):1654–8.
Price 1999
Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J,
McGready R, et al.Adverse effects in patients with acute falciparum
malaria treated with artemisinin derivatives. American Journal of
Tropical Medicine and Hygiene 1999;60(4):547–55.
Pukrittayakamee 2000
Pukrittayakamee S, Chantra A, Simpson JA, Vanijanonta S,
Clemens R, Looareesuwan S, et al.Therapeutic responses to
different antimalarial drugs in vivax malaria. Antimicrobial Agents
and Chemotherapy 2000;44(6):1680–5.
Qinghaosu 1979
Qinghaosu Antimalarial Coordinating Research Group.
Antimalarial studies on qinghaosu. Chinese Medical Journal 1979;
92:811–6.
Review Manager 5
The Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager (RevMan). 5.0. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2008.
35